Yukio Hiroi1, Hiroshi Ohtsu2, Yukari Uemura2, Kayoko Hayakawa3, Yusuke Asai4, Satoshi Kutsuna3,5, Mari Terada2,3, Wataru Sugiura2, Norio Ohmagari3. 1. Department of Cardiology, National Center for Global Health and Medicine. 2. Center for Clinical Sciences, National Center for Global Health and Medicine. 3. Disease Control and Prevention Center, National Center for Global Health and Medicine. 4. AMR Clinical Reference Center, National Center for Global Health and Medicine. 5. Department of Infection Control and Prevention, Graduate School of Medicine, Faculty of Medicine, Osaka University.
Abstract
BACKGROUND: Cardiovascular complications of coronavirus disease 2019 (COVID-19) are critical for prognosis but have not been elucidated in Japan.Methods and Results: The COVID-19 Registry Japan, which included data from 19,853 individuals at the end of 2020, was analyzed. The incidences of cardiovascular complications were 0.098% for myocarditis/pericarditis/cardiomyopathy, 0.48% for ventricular tachycardia/fibrillation, 0.17% for myocardial ischemia, 0.062% for endocarditis, 0.59% for deep vein thrombosis, 0.19% for pulmonary embolism, and 0.37% for cerebral infarction/hemorrhage. Excluding endocarditis, all complications were associated with increased in-hospital mortality. CONCLUSIONS: Cardiovascular complications of COVID-19 were infrequent in Japan but were associated with poor prognosis.
BACKGROUND: Cardiovascular complications of coronavirus disease 2019 (COVID-19) are critical for prognosis but have not been elucidated in Japan.Methods and Results: The COVID-19 Registry Japan, which included data from 19,853 individuals at the end of 2020, was analyzed. The incidences of cardiovascular complications were 0.098% for myocarditis/pericarditis/cardiomyopathy, 0.48% for ventricular tachycardia/fibrillation, 0.17% for myocardial ischemia, 0.062% for endocarditis, 0.59% for deep vein thrombosis, 0.19% for pulmonary embolism, and 0.37% for cerebral infarction/hemorrhage. Excluding endocarditis, all complications were associated with increased in-hospital mortality. CONCLUSIONS: Cardiovascular complications of COVID-19 were infrequent in Japan but were associated with poor prognosis.
Entities:
Keywords:
Cardiovascular complications; Coronavirus disease 2019 (COVID-19); National registry